| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |